Insider Transactions in Q3 2022 at Adicet Bio, Inc. (ACET)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2022
|
Chen Schor President & CEO |
SELL
Open market or private sale
|
Indirect |
952
-0.68%
|
$17,136
$18.0 P/Share
|
|
Sep 13
2022
|
Chen Schor President & CEO |
SELL
Open market or private sale
|
Indirect |
3,371
-2.36%
|
$60,678
$18.01 P/Share
|
|
Sep 12
2022
|
Chen Schor President & CEO |
SELL
Open market or private sale
|
Indirect |
66,947
-50.07%
|
$1,138,099
$17.39 P/Share
|
|
Sep 09
2022
|
Chen Schor President & CEO |
SELL
Open market or private sale
|
Indirect |
8,094
-10.81%
|
$129,504
$16.51 P/Share
|
|
Aug 04
2022
|
Chen Schor President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,288
-14.78%
|
$383,184
$18.25 P/Share
|
|
Aug 04
2022
|
Chen Schor President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
48,000
+25.0%
|
-
|
|
Aug 04
2022
|
Francesco Galimi SVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,533
-7.29%
|
$99,594
$18.25 P/Share
|
|
Aug 04
2022
|
Francesco Galimi SVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+17.41%
|
-
|
|
Aug 04
2022
|
Blake Aftab Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,533
-10.07%
|
$99,594
$18.25 P/Share
|
|
Aug 04
2022
|
Blake Aftab Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+22.55%
|
-
|
|
Aug 04
2022
|
Brian Nicholas Harvey Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,696
-6.65%
|
$84,528
$18.25 P/Share
|
|
Aug 04
2022
|
Brian Nicholas Harvey Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+18.47%
|
-
|
|
Aug 04
2022
|
Don Healey Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,533
-8.03%
|
$99,594
$18.25 P/Share
|
|
Aug 04
2022
|
Don Healey Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+18.84%
|
-
|
|
Aug 03
2022
|
Blake Aftab Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,968
-15.17%
|
$125,424
$18.0 P/Share
|
|
Aug 01
2022
|
Blake Aftab Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,968
-13.17%
|
$111,488
$16.64 P/Share
|
|
Jul 06
2022
|
Chen Schor President & CEO |
BUY
Bona fide gift
|
Indirect |
53,424
+27.16%
|
-
|
|
Jul 06
2022
|
Chen Schor President & CEO |
SELL
Bona fide gift
|
Direct |
53,424
-35.75%
|
-
|
|
Jul 05
2022
|
Blake Aftab Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,363
-2.51%
|
$19,082
$14.5 P/Share
|